Israel News

Israeli scientists conduct human trials for microsensors aiming to revolutionize heart care

The data collected by the microsensors will be used to assist heart failure specialists in making clinical decisions.

By Pesach Benson, TPS

Microtech, a subsidiary of Tel Aviv-based Medinol Inc., announced on Thursday the launch of human clinical trials for its microsensor platform aimed at improving heart failure treatment.

The first successful implantation of the device was recently performed by Prof. Erez Sharoni at Beilinson Medical Center in Petah-Tikva.

Utilizing external ultrasound communication, the microsensor enables current implants to function as smart devices, capable of gathering real-time data and performing multiple functions simultaneously.

“This amazing technology may change the standard of care for patients suffering from heart failure and in particular, in this current study, those who are receiving LVADs or heart transplants,” said Sharoni.

The data collected by the microsensors will be used to assist heart failure specialists in making clinical decisions.

“Heart failure is characterized by periods of quiescence, followed by periods of deterioration, which require repeat hospitalizations. This ground-breaking technology will allow us to track patients’ parameters in real time, to intervene earlier if needed and to reduce these patients’ morbidity and mortality” explained Dr. Tuvia Ben-Gal, Head of Heart Failure at Rabin Medical Center.

Medinol CEO Dr. Yoram Richter, CEO of Medinol said the technology could be applied clinical scenarios such as heart failure, glaucoma, hydrocephalous, portal hypertension, and more.

“Incorporating sensors into existing medical devices gives physicians the ability to treat patients based on quantifiable physiological parameters instead of symptoms and is a critical step to growing access to equitable healthcare across the global community,” Richter explained.

“Using a compact home unit, a patient with a Microtech-enabled implant can deliver immediate and highly accurate pressure readings directly to their physician turning geographical distance or mobility challenges into a non-issue.”

Share
Published by
Yossi Licht
Tags: cardiac treatment microsensor Microtech

Recent Posts

  • World News

Fetterman’s Democratic challenger was born in Gaza and ‘loves Hamas’

Fetterman accuses his Gaza-born Democratic primary challenger of sympathizing with Hamas, as Ahmed Moor calls…

6 hours ago
  • Arab-Israeli Conflict

Israeli military moved 3.5 million Palestinian photos to Amazon for AI surveillance

The photographs were transferred in early 2024 during Israel’s military offensive in Gaza.

7 hours ago
  • Videos

WATCH: Democrat influencer tries to humiliate former press secretary over Iran war support; it backfires spectacularly

Democrat social media influencer Harry Sisson claimed that if former White House Press Secretary Sean…

10 hours ago
  • Source-JFeed

’60 Minutes’: Iran hit at least 31 US sites

According to figures presented in the CBS report, 23 American troops have been killed and…

10 hours ago
  • Israel News

Likud to appeal election results in 190 Arab-sector polling stations as foreign-interference probe stalls

Likud was given the polling-station committee forms listing the names of voters at the stations…

10 hours ago
  • Videos

WATCH: IDF nabs two Hezbollah-affiliated terrorists in southern Lebanon raid

IDF forces arrested two Lebanese Brigade terrorists operating under Hezbollah’s direction in a raid near…

10 hours ago